View CNVs/SVs
View by Evidence Type: All (
CNVs Only Present In Patients
de novo CNVs
Overlapping/Recurrent CNVs
CNVs Overlapping With ACRD
CNVs Not Present In Control
Significant Enriched CNVs
Others
All
)
View by Chromosome:16 ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
| CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
|---|---|---|---|---|---|---|---|
| Case | Control | ||||||
| AutCNV0004348 | 16 | 16p11.2 | gain | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004349 | 16 | 16p11.2 | loss | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004350 | 16 | 16p11.2 | gain | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004351 | 16 | 16p11.2 | loss | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004352 | 16 | 16q22.1-q22.3 | loss | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004353 | 16 | 16q22.3 | gain | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004354 | 16 | 16q23.1 | loss | 1 | - | CNVs Only Present In Patients; | Sanders, 2011 |
| AutCNV0004355 | 16 | 16q23.2-q24.1 | loss | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004356 | 16 | 16q23.3 | loss | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004357 | 16 | 16q23.3 | loss | 1 | - | Overlapping/Recurrent CNVs; | Sanders, 2011 |
| AutCNV0004358 | 16 | 16q24.3 | loss | 1 | - | CNVs Only Present In Patients; | Sanders, 2011 |
| AutCNV0004406 | 16 | 16q23.2 | loss | 1 | - | CNVs Only Present In Patients; | Sanders, 2011 |
| AutCNV0004504 | 16 | 16p13.3 | loss | - | - | CNVs Only Present In Patients; | Nord, 2011 |
| AutCNV0004568 | 16 | 16p13.2 | Gain | 1 | - | de novo CNVs; | Patircia, 2011 |
| AutCNV0004569 | 16 | 16p11.2 | Gain | 1 | - | de novo CNVs; | Patircia, 2011 |
| AutCNV0004570 | 16 | 16q22.1 | Loss | 1 | - | de novo CNVs; | Patircia, 2011 |
| AutCNV0004571 | 16 | 16q23.2-q24.1 | Loss | 1 | - | de novo CNVs; | Patircia, 2011 |
| AutCNV0004678 | 16 | 16p13.3 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Gazzellone MJ, 2014 |
| AutCNV0004679 | 16 | 16p13.3 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Gazzellone MJ, 2014 |
| AutCNV0004680 | 16 | 16p11.2 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Gazzellone MJ, 2014 |
| AutCNV0004788 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; | Nava C, 2014 |
| AutCNV0004789 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; de novo CNVs; | Nava C, 2014 |
| AutCNV0004790 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; | Nava C, 2014 |
| AutCNV0004791 | 16 | 16p11.2 | gain | - | - | CNVs Only Present In Patients; | Nava C, 2014 |
| AutCNV0004825 | 16 | 16q21 | loss | - | - | CNVs Only Present In Patients; de novo CNVs; | Crepel A, 2014 |